Pharma Organisations try to Drive Growth
Emerging markets are predicted to account for a third of global pharmaceutical spend by the end of next year and […]
Say something
Tags: Africa, antibiotics, Brazil, BSE Sensex, Business/Finance, CAMBRIDGE CONSULTANTS LIMITED, cancer, China, chronic conditions, chronic respiratory problems, Cipla, CIPLA LIMITED, delegate, diabetes, Director, director of global pharma company, East Asia, Economics, Economy of India, Emerging markets, General Manager, Health/Medical/Pharmaceuticals, healthcare, healthcare innovation, heart disease, hypertension, India, Innovation, insurance coverage, Middle East, mumbai, neurological disorders, pharmaceutical, pharmaceutical organisations, Respiratory infections, russia, Sanjay Bhanushali, Smartphones, South East Asia, Structure, therapeutic applications
NetMeds Pan India e-Pharmacy
The Dadha Group owned NetMeds.com, an e-marketplace for pharma to offer delivery across the country announced the commencement of its […]
Ciplas Sofosbuvir to treat Hepatitis C in India
Cipla has launched a generic drug Sofosbuvir for treating chronic Hepatitis C under the brand name ‘Hepcvir’ in India. The […]
Cipla Signs JV with Moroccos Cooper Pharma and PHI
Cipla (EU) Ltd., a wholly-owned subsidiary of Mumbai based drug firm Cipla Ltd., has inked the joint venture agreement with […]
Cipla partners with Hetero to roll out biosimilar drug ‘Darbepoetin alfa’
Cipla, a global healthcare company which uses technology and innovation to meet every day needs of all patients announced a […]
-
-
Flipkart Health+ App Launched
06-04-2022
